CD8A and cancer: Our study also highlights the translational significance of combining LSD1 inhibitors with PD-1 blockade in cancer treatment, in which LSD1 inhibition in CD8+ T cells potentiates the progenitor phenotype and thus promotes long-lasting responses to PD-1 blockade.